Submitted by Anonymous (not verified) on 13 January 2026 - 15:02
Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of authorisation: 15/02/2019, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Besremi, ropeginterferon alfa-2b, Date of authorisation: 15/02/2019, Revision: 9, Status: Authorised